K. Kayan

Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study

Eugène McCloskey, Henrik J. Johansson, Anders Odén et al. · Osteoporosis International · 2008 · 139 citations

Medicine, Preventive Medicine, Bone Metabolism +12

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 40 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Can fall risk be incorporated into fracture risk assessment algorithms: a pilot study of responsiveness to clodronate

K. Kayan, Helena Johansson, Anders Odén et al. · Osteoporosis International · 2009 · 38 citations

Medicine, Orthopedic Surgery, Falls Prevention +13

Studies of Bone Density, Quantitative Ultrasound, and Vertebral Fractures in Relation to Collagen Type I Alpha 1 Alleles in Elderly Women

Robert U. Ashford, M. Luchetti, Eugène McCloskey et al. · Calcified Tissue International · 2001 · 36 citations

Medicine, Geriatric Medicine, Radiology +17